Overall, our findings highlight the clinical significance and underlying molecular mechanisms of S100A11 in HCC development and metastasis, casting a new light on the research of HCC metastasis and identifying a novel target for HCC diagnosis and treatment. This evidence concerns the gene S100A11 and hepatocellular carcinoma.